Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Olga Sala Torra, MD, Megan Othus, PhD, David W Williamson, PhD, Brent L. Wood, MD PhD, Ilan Kirsch, MD, Harlan Robins, PhD, Margaret O'Donnell, Stephen J. Forman, Frederick R. Appelbaum, MD, Jerald P Radich, MD

Blood (2014) 124 (21): 2399.

https://doi.org/10.1182/blood.V124.21.2399.2399

Published: 2014

Journal Articles

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Ilan Kirsch, MD, David W Williamson, PhD, James Krueger, MD PhD, Jessica Teague, PhD, Christopher Elco, MD PhD, Harlan Robins, PhD, Thomas S. Kupper, MD, Rachael A Clark, MDPhD

Blood (2014) 124 (21): 1683.

https://doi.org/10.1182/blood.V124.21.1683.1683

Published: 2014

Journal Articles

Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification

Ilan Kirsch, MD, Zijun Yidan Xu-Monette, PhD, Thomas Snyder, PhD, Ken H. Young, MD PhD

Blood (2014) 124 (21): 1669.

https://doi.org/10.1182/blood.V124.21.1669.1669

Published: 2014

Journal Articles

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

David Wu, MD, PhD, Ryan O Emerson, PhD, Anna Sherwood, PhD, Mignon L. Loh, MD, Anne Angiolillo, MD, Ilan Kirsch, MD, Christopher S Carlson, PhD, David Williamson, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2013) 122 (21): 2550.

https://doi.org/10.1182/blood.V122.21.2550.2550

Published: 2013

Journal Articles

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Blood (2013) 122 (21): 1341.

https://doi.org/10.1182/blood.V122.21.1341.1341

Published: 2013

NARROW

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Email alerts

ASH Publications

American Society of Hematology

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only